Cargando…

Effects of SGLT2 inhibitors on cardiovascular death and all-cause death in patients with type 2 diabetes and chronic kidney disease: an updated meta-analysis including the SCORED trial

BACKGROUND: The effects of sodium-glucose transporter 2 (SGLT2) inhibitors on cardiovascular death (CV death) and all-cause death (AC death) in patients with type 2 diabetes (T2D) and chronic kidney disease (CKD) are currently under intensive investigation. We intended to conduct an updated meta-ana...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Li-Min, Zhan, Ze-Lin, Qiu, Mei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474301/
https://www.ncbi.nlm.nih.gov/pubmed/34589202
http://dx.doi.org/10.1177/20420188211044945